Vincent C. Papa

Vincent has experience handling antitrust litigation from inception through trial and appeal. His litigation practice primarily involves defending pharmaceutical companies, health systems, and insurers against allegations of collusion, monopolization, exclusive dealing, tying, price-fixing, and violations of state antitrust, consumer protection, and business tort laws.

Recently, Vincent served as a key member of a trial team that defended an international life sciences company against novel antitrust claims allegedly arising from the company’s settlement of patent litigation. In addition, Vincent has experience arguing motions in federal court; examining witnesses in evidentiary hearings; briefing numerous pretrial motions, including motions to dismiss, for summary judgment, and opposition to class certification; and taking and defending fact and expert depositions.

Current Representative Cases

• Defending a branded pharmaceutical manufacturer against class action antitrust claims arising out of an alleged improper listing of certain patents for the diabetes drug Actos in the Orange Book
• Defending a branded pharmaceutical manufacturer against class action antitrust claims arising out of an alleged horizontal conspiracy to delay and order market entry with respect to the gout drug Colcrys
• Defending a health system and its clinically integrated network of providers against a putative class action alleging exclusive dealing, tying, and price-fixing theories